iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBerger Financial Group, Inc
Latest Disclosed Ownership2,559 shares
Latest Disclosed Value $ 432,087
Berger Financial Group, Inc reports 8.93% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Berger Financial Group, Inc filed a 13F-HR form disclosing ownership of 2,559 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $432,087 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 2,810 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -8.93% during the quarter. The current value of the position is $335,357 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,559 -251 -8.93 432 -8.86 0.0242
2026-01-27 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,810 -19 -0.67 474 16.18 0.0274
2025-10-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,829 75 2.72 408 17.24 0.0244
2025-07-22 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,754 -226 -7.58 348 -8.66 0.0225
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,980 389 15.01 381 11.40 0.0265
2025-02-14 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,591 2,591 343 0.0236
2023-11-03 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -3,728 -100.00 0 -100.00
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,728 3 0.08 473 -1.66 0.0537
2023-04-24 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,725 0 0.00 481 -1.64 0.0579
2023-01-30 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,725 0 0.00 489 12.16 0.0645
2022-10-27 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,725 -8 -0.21 436 -0.68 0.0640
2022-08-08 2022-06-30 13F Ishares Nasdaq Bio Fund ISHARES BIOTECH 464287556 3,733 -77 -2.02 439 -11.49 0.0641
2022-05-10 2022-03-31 13F Ishares Nasdaq Bio Fund ISHARES BIOTECH 464287556 3,810 0 0.00 496 -14.63 0.0630
2022-01-26 2021-12-31 13F Ishares Nasdaq Bio Fund ISHARES BIOTECH 464287556 3,810 -114 -2.91 581 -8.36 0.0770
2021-10-28 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,924 11 0.28 634 -0.94 0.1143
2021-07-29 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,913 -13 -0.33 640 8.29 0.1157
2021-05-12 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,926 808 25.91 591 25.21 0.1287
2021-02-02 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,118 3,118 472 0.0824
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.